COVID-19 and Endocrine Complications
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Endocrinology & Metabolism".
Deadline for manuscript submissions: 10 April 2026 | Viewed by 820
Special Issue Editor
Special Issue Information
Dear Colleagues,
SARS-CoV-2 infection initially causes respiratory problems, but it may also impair the function of endocrine organs, including gonads, pancreas, pituitary, adrenal, and thyroid glands. The rate of death and hospitalization is still remarkable. Furthermore, the long-term complications of acute SARS-CoV-2 infection require more investigation. The current preventive and therapeutic approaches may prevent the complications of acute SARS-CoV-2 infection, such as hospitalization and post-acute sequelae of SARS-CoV-2 infection. However, treating acute SARS-CoV-2 infection with mainly antivirals seems to be inadequate. This is primarily due to the constant changes in the genetic profile of SARS-CoV-2, which are gradually causing resistance to antivirals. In this regard, the therapeutic approaches need to be expanded on steadily, particularly by applying an alternative approach to tackle the ACE2 receptor, mitigate viral entry into the cells, reduce viral proliferation, and thus alleviate organ damages. In this Special Issue, we welcome authors to submit papers on the short- and long-term complications of COVID-19, especially endocrine complications. In addition, new approaches in terms of both the prevention and treatment of acute SARS-CoV-2 infection are welcome to be proposed.
Dr. Kamyar Asadipooya
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adrenal
- ACE2
- diabetes
- gonads
- pituitary
- SARS-CoV-2
- thyroid
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
